Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Dimberg

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
BMC Cancer|November 20, 2016
ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancerKristina Magnusson, Gabriela Gremel, Lisa Rydén, et al.
Science Immunology|January 31, 2025
Trogocytosis of chimeric antigen receptors between T cells is regulated by their transmembrane domainsStefano Barbera, Matthijs J A Schuiling, Nathaniel A Sanjaya, et al.
International Journal of Molecular Sciences|November 27, 2021
CD93 Signaling via Rho Proteins Drives Cytoskeletal Remodeling in Spreading Endothelial CellsStefano Barbera, Luisa Raucci, Roberta Lugano, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 19, 2005
Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell developmentPeetra Ulrica Magnusson, Roberto Ronca, Patrizia Dell'Era, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 2, 2014
VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-κB-induced endothelial activationHua Huang, Elise Langenkamp, Maria Georganaki, et al.
Journal of Molecular Biology|March 1, 2015
Next-generation pathology--surveillance of tumor microecologyBjörn Koos, Masood Kamali-Moghaddam, Leonor David, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2012
αB-Crystallin regulates expansion of CD11b⁺Gr-1⁺ immature myeloid cells during tumor progressionLothar C Dieterich, Petter Schiller, Hua Huang, et al.
The Journal of Clinical Investigation|May 16, 2018
CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesisRoberta Lugano, Kalyani Vemuri, Di Yu, et al.
Molecular Therapy Oncolytics|April 19, 2021
IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse gliomaMiika Martikainen, Mohanraj Ramachandran, Roberta Lugano, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|June 1, 2021
The C-type lectin CD93 controls endothelial cell migration via activation of the Rho family of small GTPasesStefano Barbera, Roberta Lugano, Alessia Pedalina, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
BMC Cancer|November 20, 2016
ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancerKristina Magnusson, Gabriela Gremel, Lisa Rydén, et al.
Science Immunology|January 31, 2025
Trogocytosis of chimeric antigen receptors between T cells is regulated by their transmembrane domainsStefano Barbera, Matthijs J A Schuiling, Nathaniel A Sanjaya, et al.
International Journal of Molecular Sciences|November 27, 2021
CD93 Signaling via Rho Proteins Drives Cytoskeletal Remodeling in Spreading Endothelial CellsStefano Barbera, Luisa Raucci, Roberta Lugano, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 19, 2005
Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell developmentPeetra Ulrica Magnusson, Roberto Ronca, Patrizia Dell'Era, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 2, 2014
VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-κB-induced endothelial activationHua Huang, Elise Langenkamp, Maria Georganaki, et al.
Journal of Molecular Biology|March 1, 2015
Next-generation pathology--surveillance of tumor microecologyBjörn Koos, Masood Kamali-Moghaddam, Leonor David, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2012
αB-Crystallin regulates expansion of CD11b⁺Gr-1⁺ immature myeloid cells during tumor progressionLothar C Dieterich, Petter Schiller, Hua Huang, et al.
The Journal of Clinical Investigation|May 16, 2018
CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesisRoberta Lugano, Kalyani Vemuri, Di Yu, et al.
Molecular Therapy Oncolytics|April 19, 2021
IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse gliomaMiika Martikainen, Mohanraj Ramachandran, Roberta Lugano, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|June 1, 2021
The C-type lectin CD93 controls endothelial cell migration via activation of the Rho family of small GTPasesStefano Barbera, Roberta Lugano, Alessia Pedalina, et al.
Pageof 9